Table 4. Association between sleep duration and risk of colorectal cancer by use of HRT in the WHI-OS (1994–2010).
HRT | Never ( n =24 681) | Ever ( n =48 986) | |||||
---|---|---|---|---|---|---|---|
Sleep duration (hours per night) | Cases a | HR b | 95% CI | Cases a | HR b | 95% CI | P -value c |
⩽5 | 41 | 1.75 | 1.23, 2.50 | 40 | 1.07 | 0.78, 1.50 | |
6 | 88 | 1.12 | 0.86, 1.45 | 134 | 1.01 | 0.82, 1.24 | |
7–8 | 174 | 1.00 | 305 | 1.00 | |||
⩾9 | 13 | 1.00 | 0.57, 1.76 | 40 | 1.70 | 1.22, 2.37 | 0.03 |
Abbreviation: cases=number of incident case; CI=confidence interval; HR=hazard ratio; HRT=hormone replacement therapy; WHI-OS=Women’s Health Initiative–Observational Study.
The analysis was based on 73 667 women who reported the use of HRT.
HR was adjusted for age, ethnicity, fatigue, waist to hip ratio, and physical activity.
P-value for interaction.